Get the latest news, insights, and market updates on KIDS (OrthoPediatrics Corp.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
WARSAW, Ind., Feb. 12, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after the market closes. OrthoPediatrics will host a conference call on Thursday, February 26, 2026 at 4:30 p.m. ET to discuss the results. Investors inte Feb 12, 2026 - $KIDS
OrthoPediatrics Announces Expanded Enabling Technology Market Opportunity
OrthoPediatrics partner iotaMotion receives FDA clearance for use of its iotaSOFT® cochlear implant insertion system in patients four years and olderWARSAW, Ind., Feb. 03, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its partner, iotaMotion, has received FDA 510(k) clearance for expanded pediatric use of its iotaSOFT® Insertion System. The system i Feb 3, 2026 - $KIDS
OrthoPediatrics (KIDS) Moves 9.8% Higher: Will This Strength Last?
OrthoPediatrics (KIDS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road. Jan 13, 2026 - $KIDS
OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance
Achieves all-time high full year 2025 Revenue of $236.1 million representing growth of 15% over prior yearInitiates guidance for record Adjusted EBITDA in 2026 WARSAW, Ind., Jan. 12, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced preliminary unaudited financial highlights for the fourth quarter and full year ended December 31, 2025, issued 2026 finan Jan 12, 2026 - $KIDS
Why The OrthoPediatrics (KIDS) Story Is Evolving After New Targets And Product Updates
Why OrthoPediatrics’ Price Target Just Shifted, Even If Only Slightly OrthoPediatrics’ fair value estimate has been nudged from about US$24.14 to roughly US$24.13 per share, a tiny move that still reflects a fresh look at the company’s revenue outlook and risk profile rather than a new story for the stock. Analysts are essentially fine tuning their models around revenue growth assumptions and execution risk, using the latest guidance and quarterly results as a cleaner baseline for what comes... Jan 11, 2026 - $KIDS
Why The Narrative Around OrthoPediatrics Is Changing With New Guidance And Analyst Reactions
OrthoPediatrics has recently seen its price target adjusted, with the Fair Value estimate holding steady at $24.14, even as analyst sentiment remains divided. Some highlight the company’s ongoing strength in its core business and sustained revenue growth projections. Others point to execution challenges and persistent international headwinds. Stay tuned to discover how you can follow future developments and shifts in perspective surrounding OrthoPediatrics’ evolving narrative. Analyst Price... Nov 28, 2025 - $KIDS
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Product Launches
WARSAW, Ind., Nov. 13, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing (“OPSB”) portfolio with two new products launches, the PediHip™ Rigid Brace and PediHip™ Modular Abduction Systems. The company now has 31 systems within its OPSB division. Developed in collaboration with globally recognized pe Nov 13, 2025 - $KIDS
Wall Street Analysts Believe OrthoPediatrics (KIDS) Could Rally 41.92%: Here's is How to Trade
The consensus price target hints at a 41.9% upside potential for OrthoPediatrics (KIDS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. Nov 10, 2025 - $KIDS
What Catalysts Could Shift the OrthoPediatrics Story After Analyst Revisions?
OrthoPediatrics stock recently saw its consensus analyst price target lowered from $26.29 to $24.14. This change reflects a more cautious stance from the investment community. The adjustment comes after analysts weighed short-term challenges against the company's long-term prospects, signaling a shift in sentiment amid mixed research commentary. Stay tuned to learn how you can track ongoing updates and shifts in the narrative surrounding OrthoPediatrics stock. Analyst Price Targets don't... Nov 9, 2025 - $KIDS
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple